ModivCare Inc. (MODV)
USD 1.29
(13.16%)
USD 1.29
(13.16%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.13 Billion USD | 12.98% |
| 2022 | 1 Billion USD | 13.55% |
| 2021 | 886.48 Million USD | 165.05% |
| 2020 | 334.45 Million USD | 940.77% |
| 2019 | -39.78 Million USD | -763.47% |
| 2018 | -4.6 Million USD | 95.01% |
| 2017 | -92.32 Million USD | -34.49% |
| 2016 | -68.65 Million USD | -131.34% |
| 2015 | 219.07 Million USD | -47.19% |
| 2014 | 414.8 Million USD | 1592.74% |
| 2013 | 24.5 Million USD | -66.95% |
| 2012 | 74.13 Million USD | -30.91% |
| 2011 | 107.3 Million USD | -11.35% |
| 2010 | 121.04 Million USD | -20.92% |
| 2009 | 153.05 Million USD | -26.55% |
| 2008 | 208.39 Million USD | -0.78% |
| 2007 | 210.04 Million USD | 628.38% |
| 2006 | -39.75 Million USD | -526.06% |
| 2005 | 9.32 Million USD | 197.98% |
| 2004 | -9.52 Million USD | 14.85% |
| 2003 | -11.18 Million USD | -182.85% |
| 2002 | 13.49 Million USD | -98.66% |
| 2001 | 1 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.13 Billion USD | 0.11% |
| 2024 Q2 | 1.19 Billion USD | 5.36% |
| 2023 Q3 | 1.09 Billion USD | -3.76% |
| 2023 Q1 | 1.02 Billion USD | 1.85% |
| 2023 Q4 | 1.13 Billion USD | 3.4% |
| 2023 FY | 1.13 Billion USD | 12.98% |
| 2023 Q2 | 1.14 Billion USD | 11.46% |
| 2022 FY | 1 Billion USD | 13.55% |
| 2022 Q1 | 826.12 Million USD | -6.81% |
| 2022 Q2 | 931.78 Million USD | 12.79% |
| 2022 Q3 | 946.32 Million USD | 1.56% |
| 2022 Q4 | 1 Billion USD | 6.37% |
| 2021 Q1 | 217.28 Million USD | -35.03% |
| 2021 Q2 | 237.71 Million USD | 9.4% |
| 2021 Q3 | 892.83 Million USD | 275.59% |
| 2021 FY | 886.48 Million USD | 165.05% |
| 2021 Q4 | 886.48 Million USD | -0.71% |
| 2020 Q1 | -72.37 Million USD | -81.93% |
| 2020 Q3 | -163.43 Million USD | -690.11% |
| 2020 Q2 | -20.68 Million USD | 71.42% |
| 2020 FY | 334.45 Million USD | 940.77% |
| 2020 Q4 | 334.45 Million USD | 304.64% |
| 2019 Q4 | -39.78 Million USD | -112.97% |
| 2019 FY | -39.78 Million USD | -763.47% |
| 2019 Q1 | -19.12 Million USD | -315.15% |
| 2019 Q2 | -8.59 Million USD | 55.06% |
| 2019 Q3 | -18.67 Million USD | -117.32% |
| 2018 Q2 | -27.47 Million USD | 67.24% |
| 2018 Q3 | -9.91 Million USD | 63.93% |
| 2018 Q4 | -4.6 Million USD | 53.53% |
| 2018 FY | -4.6 Million USD | 95.01% |
| 2018 Q1 | -83.87 Million USD | 9.16% |
| 2017 Q4 | -92.32 Million USD | -2.49% |
| 2017 Q2 | -53.53 Million USD | 33.03% |
| 2017 FY | -92.32 Million USD | -34.49% |
| 2017 Q1 | -79.94 Million USD | -16.45% |
| 2017 Q3 | -90.08 Million USD | -68.27% |
| 2016 Q3 | 270.53 Million USD | 13.07% |
| 2016 Q4 | -68.65 Million USD | -125.38% |
| 2016 FY | -68.65 Million USD | -131.34% |
| 2016 Q1 | 212.63 Million USD | -2.94% |
| 2016 Q2 | 239.25 Million USD | 12.52% |
| 2015 Q1 | 333.89 Million USD | -19.51% |
| 2015 FY | 219.07 Million USD | -47.19% |
| 2015 Q4 | 219.07 Million USD | -41.63% |
| 2015 Q2 | 343.16 Million USD | 2.78% |
| 2015 Q3 | 375.31 Million USD | 9.37% |
| 2014 Q1 | 17.66 Million USD | -27.93% |
| 2014 Q2 | 68.6 Million USD | 288.45% |
| 2014 FY | 414.8 Million USD | 1592.74% |
| 2014 Q4 | 414.8 Million USD | 658.3% |
| 2014 Q3 | 54.7 Million USD | -20.26% |
| 2013 Q1 | 44.17 Million USD | -40.42% |
| 2013 Q4 | 24.5 Million USD | -24.36% |
| 2013 Q3 | 32.39 Million USD | -34.59% |
| 2013 FY | 24.5 Million USD | -66.95% |
| 2013 Q2 | 49.52 Million USD | 12.13% |
| 2012 Q2 | 95.31 Million USD | -5.57% |
| 2012 Q4 | 74.13 Million USD | -3.4% |
| 2012 FY | 74.13 Million USD | -30.91% |
| 2012 Q1 | 100.93 Million USD | -5.94% |
| 2012 Q3 | 76.74 Million USD | -19.48% |
| 2011 Q3 | 104.48 Million USD | -7.83% |
| 2011 FY | 107.3 Million USD | -11.35% |
| 2011 Q4 | 107.3 Million USD | 2.7% |
| 2011 Q2 | 113.35 Million USD | 0.87% |
| 2011 Q1 | 112.38 Million USD | -7.15% |
| 2010 Q1 | 140.07 Million USD | -8.48% |
| 2010 FY | 121.04 Million USD | -20.92% |
| 2010 Q4 | 121.04 Million USD | -0.22% |
| 2010 Q3 | 121.31 Million USD | -10.41% |
| 2010 Q2 | 135.41 Million USD | -3.33% |
| 2009 FY | 153.05 Million USD | -26.55% |
| 2009 Q1 | 202.04 Million USD | -3.05% |
| 2009 Q2 | 191.92 Million USD | -5.01% |
| 2009 Q3 | 168.75 Million USD | -12.07% |
| 2009 Q4 | 153.05 Million USD | -9.3% |
| 2008 FY | 208.39 Million USD | -0.78% |
| 2008 Q4 | 208.39 Million USD | 3.09% |
| 2008 Q3 | 202.14 Million USD | 0.06% |
| 2008 Q2 | 202.02 Million USD | 4.1% |
| 2008 Q1 | 194.05 Million USD | -7.61% |
| 2007 FY | 210.04 Million USD | 628.38% |
| 2007 Q4 | 210.04 Million USD | 1210.3% |
| 2007 Q2 | -22.32 Million USD | 25.85% |
| 2007 Q1 | -30.1 Million USD | 24.28% |
| 2007 Q3 | -18.91 Million USD | 15.25% |
| 2006 Q4 | -39.75 Million USD | -1.37% |
| 2006 Q3 | -39.21 Million USD | 10.9% |
| 2006 Q2 | -44.01 Million USD | -510.2% |
| 2006 FY | -39.75 Million USD | -526.06% |
| 2006 Q1 | 10.72 Million USD | 14.99% |
| 2005 Q3 | 9.9 Million USD | 744.9% |
| 2005 Q2 | -1.53 Million USD | 87.58% |
| 2005 Q1 | -12.36 Million USD | -29.88% |
| 2005 Q4 | 9.32 Million USD | -5.84% |
| 2005 FY | 9.32 Million USD | 197.98% |
| 2004 Q3 | -10.63 Million USD | 27.78% |
| 2004 Q2 | -14.72 Million USD | -87.62% |
| 2004 Q1 | -7.84 Million USD | 29.81% |
| 2004 Q4 | -9.52 Million USD | 10.47% |
| 2004 FY | -9.52 Million USD | 14.85% |
| 2003 Q4 | -11.18 Million USD | 7.81% |
| 2003 FY | -11.18 Million USD | -182.85% |
| 2003 Q3 | -12.13 Million USD | -163.67% |
| 2003 Q2 | 19.05 Million USD | 0.0% |
| 2002 FY | 13.49 Million USD | -98.66% |
| 2001 Q4 | 1 Billion USD | 0.0% |
| 2001 FY | 1 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 19.379% |
| Addus HomeCare Corporation | 110.39 Million USD | -930.234% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -1172.047% |
| Amedisys, Inc. | 341.35 Million USD | -233.173% |
| American Oncology Network, Inc. | 99.78 Million USD | -1039.725% |
| Astrana Health, Inc. | 27.2 Million USD | -4080.123% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 21.85% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 513521.907% |
| biote Corp. | 25.86 Million USD | -4296.328% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -10741.659% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 9716.014% |
| COMPASS Pathways plc | -187.58 Million USD | 706.268% |
| DocGo Inc. | -12.78 Million USD | 8992.686% |
| The Ensign Group, Inc. | 1.36 Billion USD | 16.479% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 10733.81% |
| InnovAge Holding Corp. | 56.08 Million USD | -1927.645% |
| Assure Holdings Corp. | 14.68 Million USD | -7646.125% |
| The Joint Corp. | -2.47 Million USD | 45968.294% |
| LifeStance Health Group, Inc. | 432.21 Million USD | -163.128% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 18896.37% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -408336.015% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -27944.256% |
| Option Care Health, Inc. | 822.56 Million USD | -38.261% |
| P3 Health Partners Inc. | 83.7 Million USD | -1258.651% |
| P3 Health Partners Inc. | 83.7 Million USD | -1258.651% |
| The Pennant Group, Inc. | 323.57 Million USD | -251.477% |
| Surgery Partners, Inc. | 2.86 Billion USD | 60.314% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 37609.779% |
| Talkspace, Inc. | -123.9 Million USD | 1017.847% |
| Talkspace, Inc. | -123.9 Million USD | 1017.847% |
| The Oncology Institute, Inc. | 86.32 Million USD | -1217.416% |
| The Oncology Institute, Inc. | 86.32 Million USD | -1217.416% |